Prothrombotic phenotype in COVID-19 severe patients.
作者信息
Helms Julie, Severac François, Merdji Hamid, Anglés-Cano Eduardo, Meziani Ferhat
机构信息
Hôpitaux Universitaires de Strasbourg, Service de Médecine Intensive Réanimation, Nouvel Hôpital Civil, 1, place de l'Hôpital, 67091, Strasbourg cedex, France.
ImmunoRhumatologie Moléculaire, INSERM UMR_S1109, LabEx TRANSPLANTEX, Centre de Recherche d'Immunologie et d'Hématologie, Faculté de Médecine, Fédération Hospitalo-Universitaire (FHU) OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg (UNISTRA), Strasbourg, France.
出版信息
Intensive Care Med. 2020 Jul;46(7):1502-1503. doi: 10.1007/s00134-020-06082-7. Epub 2020 May 20.
Abstract
摘要
相似文献
1
Prothrombotic phenotype in COVID-19 severe patients.
Intensive Care Med. 2020 Jul;46(7):1502-1503. doi: 10.1007/s00134-020-06082-7. Epub 2020 May 20.
2
[Six cases of acute pulmonary embolism associated with COVID-19].
Rev Med Liege. 2020;75(S1):94-100.
3
COVID-19 and pulmonary embolism: an unwanted alliance.
Eur Heart J. 2020 Jul 1;41(32):3069-3071. doi: 10.1093/eurheartj/ehaa553.
4
Acute pulmonary embolism in COVID-19 disease.
Int J Cardiol. 2020 Nov 15;319:151. doi: 10.1016/j.ijcard.2020.06.063. Epub 2020 Jul 3.
5
COVID-19 and Pulmonary Embolism: Diagnostic Imaging Trends.
J Nucl Med. 2020 Aug;61(8):1102. doi: 10.2967/jnumed.120.248518. Epub 2020 May 22.
6
Reply: COVID-19 and Pulmonary Embolism: Diagnostic Imaging Trends.
J Nucl Med. 2020 Aug;61(8):1102-1103. doi: 10.2967/jnumed.120.250530. Epub 2020 Jun 23.
7
SARS-Cov-2 Infection and Pulmonary Thromboembolism - The Prothrombotic State in COVID-19.
Arq Bras Cardiol. 2020 Jul;115(1):142-145. doi: 10.36660/abc.20200427. Epub 2020 Aug 7.
8
[Venous thromboembolism in patients with COVID-19].
Ugeskr Laeger. 2020 Jun 1;182(23).
9
Are subpleural consolidations indicators for segmental pulmonary embolism in COVID-19?
Intensive Care Med. 2020 Jun;46(6):1109-1110. doi: 10.1007/s00134-020-06044-z. Epub 2020 Apr 23.
10
Incidence of pulmonary embolism in patients with COVID-19.
Intensive Care Med. 2020 Jul;46(7):1500-1501. doi: 10.1007/s00134-020-06081-8. Epub 2020 May 20.
引用本文的文献
1
Venous thromboembolism and severe COVID-19: a Mendelian randomization trial and transcriptomic analysis.
Front Immunol. 2024 Apr 29;15:1363598. doi: 10.3389/fimmu.2024.1363598. eCollection 2024.
2
The evolution of preexisting primary immune thrombocytopenia after COVID-19 onset: A nationally representative, prospective, multicentre, observational study.
Ann Hematol. 2024 May;103(5):1549-1559. doi: 10.1007/s00277-024-05720-0. Epub 2024 Mar 25.
3
Case report: Tissue positivity for SARS-CoV-2 in a preterm born infant death of thrombosis: possible intrauterine transmission.
Front Med (Lausanne). 2023 May 11;10:1127529. doi: 10.3389/fmed.2023.1127529. eCollection 2023.
4
Vascular dysfunction in COVID-19 patients: update on SARS-CoV-2 infection of endothelial cells and the role of long non-coding RNAs.
Clin Sci (Lond). 2022 Nov 11;136(21):1571-1590. doi: 10.1042/CS20220235.
5
Advanced cell therapy with low tissue factor loaded product NestaCell® does not confer thrombogenic risk for critically ill COVID-19 heparin-treated patients.
Biomed Pharmacother. 2022 May;149:112920. doi: 10.1016/j.biopha.2022.112920. Epub 2022 Apr 1.
6
Case report of a Japanese patient with chronic renal failure who developed SARS-CoV-2 in a hospital cluster during treatment for acute respiratory failure: An autopsy report.
Clin Case Rep. 2022 Jul 11;10(7):e6024. doi: 10.1002/ccr3.6024. eCollection 2022 Jul.
7
Report of Low Incidence of Thrombosis with Early Prophylaxis in Hospitalized Patients with COVID-19 from Two Saudi Tertiary Centers.
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221086286. doi: 10.1177/10760296221086286.
8
COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences.
Front Cell Dev Biol. 2022 Feb 15;10:824851. doi: 10.3389/fcell.2022.824851. eCollection 2022.
9
Daily Monitoring of D-Dimer Allows Outcomes Prediction in COVID-19.
TH Open. 2021 Nov 30;6(1):e21-e25. doi: 10.1055/a-1709-5441. eCollection 2022 Jan.
10
Serum troponin, D-dimer, and CRP level in severe coronavirus (COVID-19) patients.
Immun Inflamm Dis. 2022 Mar;10(3):e582. doi: 10.1002/iid3.582. Epub 2021 Dec 22.
本文引用的文献
1
Incidence of pulmonary embolism in patients with COVID-19.
Intensive Care Med. 2020 Jul;46(7):1500-1501. doi: 10.1007/s00134-020-06081-8. Epub 2020 May 20.
2
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4.
3
Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence.
Circulation. 2020 Jul 14;142(2):184-186. doi: 10.1161/CIRCULATIONAHA.120.047430. Epub 2020 Apr 24.
4
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients.
J Thromb Haemost. 2020 Jul;18(7):1743-1746. doi: 10.1111/jth.14869. Epub 2020 May 27.
5
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
Zotero 插件